BioCentury | Dec 14, 2018
Financial News

Zymergen raises more than $400M in series C

...in a series C round led by SoftBank Vision Fund. New investors Goldman Sachs and Hanwha...
BioCentury | Nov 21, 2016
Strategy

LG’s biotech legacy

...the oncology exodus. He then spent two years as head of the biobusiness unit at Hanwha...
...Sang Hoon Lee also has founded a new company, following a stint as head of Hanwha...
...investors. While Lee did not spend time at LG, his experience at Western biotechs and Hanwha...
BioCentury | Jul 25, 2016
Strategy

Paving the way

.../ Biogen Inc. (NASDAQ:BIIB) / Merck & Co. Inc. (NYSE:MRK) Mkt in EU, South Korea Hanwha...
BioCentury | Jan 25, 2016
Strategy

Productive partnership

...and certain Caribbean and Latin American countries. CHS-0214 entered Phase III testing in July 2014. Hanwha...
...Mass. Coherus BioSciences Inc. (NASDAQ:CHRS), Redwood City, Calif. European Medicines Agency (EMA) , London, U.K. Hanwha...
BioCentury | Aug 22, 2013
Strategy

Found in translation: Institute Pasteur Korea

...Pasteur Institute, the provincial government of Gyeonggi-do, and venture investors Atinum Investment Co. Ltd. , Hanwha...
...Ltd. (KOSDAQ:021080), Seoul, South Korea Global Alliance for TB Drug Development , New York, N.Y. Hanwha...
BioCentury | Nov 5, 2012
Finance

Korean POC

...with co-manager Hanwha Investment Corp., the VC arm of conglomerate Hanwha Group . Oxford and Hanwha...
BioCentury | Mar 5, 2012
Finance

Putting debt to work

...Investment. The private placement was with Korea Seoul Life Sciences Fund (KSLSF), whose GPs are Hanwha...
BioCentury | Jan 2, 2012
Strategy

Elementary, Watson

...Holdings Corp. , which announced a partnership in November, and Merck & Co. Inc. and Hanwha...
...NYSE:BAX), Deerfield, Ill. Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan Hanwha...
BioCentury | Dec 5, 2011
Company News

Amgen autoimmune news

...& Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.) is developing a biosimilar version of etanercept with Hanwha...
BioCentury | Nov 24, 2011
Company News

PTO issues Enbrel patent

...biosimilar challenge. Merck & Co. Inc. (NYSE:MRK) is developing a biosimilar version of etanercept with Hanwha...
Items per page:
1 - 10 of 14
BioCentury | Dec 14, 2018
Financial News

Zymergen raises more than $400M in series C

...in a series C round led by SoftBank Vision Fund. New investors Goldman Sachs and Hanwha...
BioCentury | Nov 21, 2016
Strategy

LG’s biotech legacy

...the oncology exodus. He then spent two years as head of the biobusiness unit at Hanwha...
...Sang Hoon Lee also has founded a new company, following a stint as head of Hanwha...
...investors. While Lee did not spend time at LG, his experience at Western biotechs and Hanwha...
BioCentury | Jul 25, 2016
Strategy

Paving the way

.../ Biogen Inc. (NASDAQ:BIIB) / Merck & Co. Inc. (NYSE:MRK) Mkt in EU, South Korea Hanwha...
BioCentury | Jan 25, 2016
Strategy

Productive partnership

...and certain Caribbean and Latin American countries. CHS-0214 entered Phase III testing in July 2014. Hanwha...
...Mass. Coherus BioSciences Inc. (NASDAQ:CHRS), Redwood City, Calif. European Medicines Agency (EMA) , London, U.K. Hanwha...
BioCentury | Aug 22, 2013
Strategy

Found in translation: Institute Pasteur Korea

...Pasteur Institute, the provincial government of Gyeonggi-do, and venture investors Atinum Investment Co. Ltd. , Hanwha...
...Ltd. (KOSDAQ:021080), Seoul, South Korea Global Alliance for TB Drug Development , New York, N.Y. Hanwha...
BioCentury | Nov 5, 2012
Finance

Korean POC

...with co-manager Hanwha Investment Corp., the VC arm of conglomerate Hanwha Group . Oxford and Hanwha...
BioCentury | Mar 5, 2012
Finance

Putting debt to work

...Investment. The private placement was with Korea Seoul Life Sciences Fund (KSLSF), whose GPs are Hanwha...
BioCentury | Jan 2, 2012
Strategy

Elementary, Watson

...Holdings Corp. , which announced a partnership in November, and Merck & Co. Inc. and Hanwha...
...NYSE:BAX), Deerfield, Ill. Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan Hanwha...
BioCentury | Dec 5, 2011
Company News

Amgen autoimmune news

...& Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.) is developing a biosimilar version of etanercept with Hanwha...
BioCentury | Nov 24, 2011
Company News

PTO issues Enbrel patent

...biosimilar challenge. Merck & Co. Inc. (NYSE:MRK) is developing a biosimilar version of etanercept with Hanwha...
Items per page:
1 - 10 of 14